Srinivas Akkaraju - May 26, 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Stock symbol
KDNY
Transactions as of
May 26, 2022
Transactions value $
$0
Form type
4
Date filed
5/31/2022, 06:04 PM
Previous filing
May 27, 2022
Next filing
Jun 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Stock Option (Right to Buy) Award $0 +13.3K $0.00 13.3K May 26, 2022 Common Stock 13.3K $13.88 Direct F1
transaction KDNY Restricted Stock Unit Award $0 +3.3K $0.00 3.3K May 26, 2022 Common Stock 3.3K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the stock option will vest on May 26, 2023, subject to the Reporting Person's continued service to the Issuer on the vesting date.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F3 100% of the RSUs will vest on May 26, 2023, subject to the Reporting Person's continued service to the Issuer on the vesting date.